Performance of a dual-hormone closed-loop system versus insulin-only closed-loop system in adolescents with type 1 diabetes. A single-blind, randomized, controlled, crossover trial

被引:3
作者
Lindkvist, Emilie Bundgaard [1 ,2 ]
Laugesen, Christian [1 ,2 ]
Reenberg, Asbjorn Thode [3 ]
Ritschel, Tobias Kasper Skov [3 ]
Svensson, Jannet [1 ,4 ]
Jorgensen, John Bagterp [3 ]
Norgaard, Kirsten [1 ,2 ]
Ranjan, Ajenthen G. G. [1 ,5 ]
机构
[1] Copenhagen Univ Hosp, Steno Diabet Ctr Copenhagen, Herlev, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark
[3] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark
[4] Herlev & Gentofte Univ Hosp, Dept Pediat, Herlev, Denmark
[5] Danish Diabet Acad, Odense, Denmark
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
type 1 diabetes mellitus; adolescents; dual-hormone; advanced hybrid closed-loop; artificial pancreas; non-linear model predictive control; moderate intensity continuous exercise; ARTIFICIAL PANCREAS; OPEN-LABEL; GLYCEMIC CONTROL; PUMP THERAPY; GLUCOSE; OUTPATIENT; PAIN;
D O I
10.3389/fendo.2023.1073388
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo assess the efficacy and safety of a dual-hormone (DH [insulin and glucagon]) closed-loop system compared to a single-hormone (SH [insulin only]) closed-loop system in adolescents with type 1 diabetes. MethodsThis was a 26-hour, two-period, randomized, crossover, inpatient study involving 11 adolescents with type 1 diabetes (nine males [82%], mean +/- SD age 14.8 +/- 1.4 years, diabetes duration 5.7 +/- 2.3 years). Except for the treatment configuration of the DiaCon Artificial Pancreas: DH or SH, experimental visits were identical consisting of: an overnight stay (10:00 pm until 7:30 am), several meals/snacks, and a 45-minute bout of moderate intensity continuous exercise. The primary endpoint was percentage of time spent with sensor glucose values below range (TBR [<3.9 mmol/L]) during closed-loop control over the 26-h period (5:00 pm, day 1 to 7:00 pm, day 2). ResultsOverall, there were no differences between DH and SH for the following glycemic outcomes (median [IQR]): TBR 1.6 [0.0, 2.4] vs. 1.28 [0.16, 3.19]%, p=1.00; time in range (TIR [3.9-10.0 mmol/L]) 68.4 [48.7, 76.8] vs. 75.7 [69.8, 87.1]%, p=0.08; and time above range (TAR [>10.0 mmol/L]) 28.1 [18.1, 49.8] vs. 23.3 [12.3, 27.2]%, p=0.10. Mean ( +/- SD) glucose was higher during DH than SH (8.7 ( +/- 3.2) vs. 8.1 ( +/- 3.0) mmol/L, p<0.001) but coefficient of variation was similar (34.8 ( +/- 6.8) vs. 37.3 ( +/- 8.6)%, p=0.20). The average amount of rescue carbohydrates was similar between DH and SH (6.8 ( +/- 12.3) vs. 9.5 ( +/- 15.4) grams/participant/visit, p=0.78). Overnight, TIR was higher, TAR was lower during the SH visit compared to DH. During and after exercise (4:30 pm until 7 pm) the SH configuration produced higher TIR, but similar TAR and TBR compared to the DH configuration. ConclusionsDH and SH performed similarly in adolescents with type 1 diabetes during a 26-hour inpatient monitoring period involving several metabolic challenges including feeding and exercise. However, during the night and around exercise, the SH configuration outperformed DH.
引用
收藏
页数:10
相关论文
共 30 条
  • [1] [Anonymous], MCDONALDS NUTR CALCU
  • [2] Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis
    Bekiari, Eleni
    Kitsios, Konstantinos
    Thabit, Hood
    Tauschmann, Martin
    Athanasiadou, Eleni
    Karagiannis, Thomas
    Haidich, Anna-Bettina
    Hovorka, Roman
    Tsapas, Apostolos
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2018, 361
  • [3] Switching from predictive low glucose suspend to advanced hybrid closed loop control: Effects on glucose control and patient reported outcomes
    Boscari, Federico
    Ferretto, Sara
    Cavallin, Francesco
    Bruttomesso, Daniela
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 185
  • [4] Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
    Castellanos, Luz E.
    Balliro, Courtney A.
    Sherwood, Jordan S.
    Jafri, Rabab
    Hillard, Mallory A.
    Greaux, Evelyn
    Selagamsetty, Rajendranath
    Zheng, Hui
    El-Khatib, Firas H.
    Damiano, Edward R.
    Russell, Steven J.
    [J]. DIABETES CARE, 2021, 44 (06) : E118 - E120
  • [5] Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors
    Castle, Jessica R.
    El Youssef, Joseph
    Wilson, Leah M.
    Reddy, Ravi
    Resalat, Navid
    Branigan, Deborah
    Ramsey, Katrina
    Leitschuh, Joseph
    Rajhbeharrysingh, Uma
    Senf, Brian
    Sugerman, Samuel M.
    Gabo, Virginia
    Jacobs, Peter G.
    [J]. DIABETES CARE, 2018, 41 (07) : 1471 - 1477
  • [6] Age-Based Prediction of Maximal Heart Rate in Children and Adolescents: A Systematic Review and Meta-Analysis
    Cicone, Zackary S.
    Holmes, Clifton J.
    Fedewa, Michael V.
    MacDonald, Hayley V.
    Esco, Michael R.
    [J]. RESEARCH QUARTERLY FOR EXERCISE AND SPORT, 2019, 90 (03) : 417 - 428
  • [7] Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial
    El-Khatib, Firas H.
    Balliro, Courtney
    Hillard, Mallory A.
    Magyar, Kendra L.
    Ekhlaspour, Laya
    Sinha, Manasi
    Mondesir, Debbie
    Esmaeili, Aryan
    Hartigan, Celia
    Thompson, Michael J.
    Malkani, Samir
    Lock, J. Paul
    Harlan, David M.
    Clinton, Paula
    Frank, Eliana
    Wilson, Darrell M.
    DeSalvo, Daniel
    Norlander, Lisa
    Ly, Trang
    Buckingham, Bruce A.
    Diner, Jamie
    Dezube, Milana
    Young, Laura A.
    Goley, April
    Kirkman, M. Sue
    Buse, John B.
    Zheng, Hui
    Selagamsetty, Rajendranath R.
    Damiano, Edward R.
    Russell, Steven J.
    [J]. LANCET, 2017, 389 (10067) : 369 - 380
  • [8] Reliability and validity of a visual analog scale for acute abdominal pain in the ED
    Gallagher, EJ
    Bijur, PE
    Latimer, C
    Silver, W
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2002, 20 (04) : 287 - 290
  • [9] Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up
    Gubitosi-Klug, Rose A.
    Lachin, John M.
    Backlund, Jye-Yu C.
    Lorenzi, Gayle M.
    Brillon, David J.
    Orchard, Trevor J.
    [J]. DIABETES CARE, 2016, 39 (05) : 686 - 693
  • [10] Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes
    Haidar, Ahmad
    Rabasa-Lhoret, Remi
    Legault, Laurent
    Lovblom, Leif E.
    Rakheja, Rohan
    Messier, Virginie
    D'Aoust, Emilie
    Falappa, C. Marcelo
    Justice, Tara
    Orszag, Andrej
    Tschirhart, Holly
    Dallaire, Maryse
    Ladouceur, Martin
    Perkins, Bruce A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (01) : 213 - 222